Literature DB >> 27269503

Protective Role of Hinokitiol Against H2O2-Induced Injury in Human Corneal Epithelium.

Yufeng Xu1, Shengzhan Wang1, Qi Miao1, Kai Jin1, Lixia Lou1, Xin Ye1, Yan Xi1, Juan Ye1.   

Abstract

PURPOSE: We recently found that hinokitiol has anti-inflammatory activity in human corneal epithelial (HCE) cells. Herein, we investigated the protective role of hinokitiol against H2O2-induced injury in HCE cells and the mechanisms that underlie its action.
METHODS: HCE cells were incubated with different concentrations of hinokitiol or dimethylsulfoxide (DMSO), which served as a vehicle control, before H2O2 stimulus. The cell viability was evaluated using a cell counting kit-8 (CCK-8) assay. TUNEL, phosphorylated histone γH2A.X, cleaved caspase-3 expression analyses, and location of cytochrome c were conducted to detect cell injury and apoptosis. Reactive oxygen species (ROS), catalase (CAT), superoxide dismutase (SOD), methane dicarboxylic aldehyde (MDA), and total antioxidative capacity (T-AOC) were used to determine oxidative stress. Bcl-2 and Bax protein expressions were measured by western blotting.
RESULTS: Hinokitiol significantly improved the cell viability, decreased the apoptosis rate, inhibited DNA damage, and reduced cleaved caspase-3 expression and the leakage of cytochrome c from mimitochondrion to cytoplasm of HCE cells against the oxidative stress induced by H2O2. Generation of ROS and MDA and decreased activity of CAT, SOD, and T-AOC were also ameliorated by hinokitiol administration. Moreover, Bcl-2 expression was down-regulated while Bax was up-regulated by H2O2 stimulus, which were reversed by hinokitiol application.
CONCLUSION: Hinokitiol protects HCE cells against H2O2-induced injury likely by its antioxidant activity and modulating the Bcl-2 signaling pathway.

Entities:  

Keywords:  Antioxidant; ROS; apoptosis; hinokitiol; human corneal epithelial cells

Mesh:

Substances:

Year:  2016        PMID: 27269503     DOI: 10.3109/02713683.2016.1151530

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Beneficial Effects of Polydeoxyribonucleotide (PDRN) in an In Vitro Model of Fuchs Endothelial Corneal Dystrophy.

Authors:  Ida Ceravolo; Federica Mannino; Natasha Irrera; Letteria Minutoli; Vincenzo Arcoraci; Domenica Altavilla; Gian Maria Cavallini; Salvatore Guarini; Francesco Squadrito; Giovanni Pallio
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-03

2.  Hinokitiol Protects Cardiomyocyte from Oxidative Damage by Inhibiting GSK3β-Mediated Autophagy.

Authors:  Hongkai Xiao; Siyu Liang; Qinhong Cai; Jinghu Liu; Liang Jin; Zhengfei Yang; Xiaochao Chen
Journal:  Oxid Med Cell Longev       Date:  2022-04-04       Impact factor: 6.543

3.  JMJD6 Dysfunction Due to Iron Deficiency in Preeclampsia Disrupts Fibronectin Homeostasis Resulting in Diminished Trophoblast Migration.

Authors:  Sruthi Alahari; Abby Farrell; Leonardo Ermini; Chanho Park; Julien Sallais; Sarah Roberts; Taylor Gillmore; Michael Litvack; Martin Post; Isabella Caniggia
Journal:  Front Cell Dev Biol       Date:  2021-05-12

4.  Experimental and Clinical Applications of Chamaecyparis obtusa Extracts in Dry Eye Disease.

Authors:  Lian Cui; Hyo Seok Lee; Ying Li; Joo-Hee Choi; Je-Jung Yun; Ji Eun Jung; Won Choi; Kyung Chul Yoon
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

5.  Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model.

Authors:  Toshihito Isono; Hisanori Domon; Kosuke Nagai; Tomoki Maekawa; Hikaru Tamura; Takumi Hiyoshi; Katsunori Yanagihara; Eiji Kunitomo; Shoji Takenaka; Yuichiro Noiri; Yutaka Terao
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.